Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Broncho-Vaxom

Known as: broncho vaxom 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Background Oral administration of bacterial extracts (eg, Broncho-Vaxom (BV)) has been proposed to attenuate asthma through… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Background According to the hygiene hypothesis, bacterial infections during early life contribute to a reduced incidence of… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2011
Highly Cited
2011
INTRODUCTION Allergic asthma is a Th2 lymphocyte-mediated inflammatory airway disease. It is characterized by airway eosinophilia… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2010
Highly Cited
2010
BACKGROUND No reagents have been shown to be effective in preventing wheezing attacks provoked by acute respiratory tract… Expand
  • figure 1
  • table I
  • table II
  • table III
  • table IV
2006
2006
With great interest we read the articles of Siu et al. [1] and Maindrault-Goebel et al. [2]. Both report on immediate type… Expand
2002
2002
OBJECTIVES To investigate the effects of Uro-Vaxom, an oral vaccine against Escherichia coli urinary tract infections, on human… Expand
2001
2001
Dendritic cells (DCs) are important antigen-presenting cells of the immune system that have attracted interest as cellular… Expand
1996
1996
BACKGROUND: Broncho-Vaxom (OM-85 BV) increases the resistance of the respiratory tract to bacterial infections by modulating host… Expand
1995
1995
Possibilities of combined radioprotection, using preirradiation WR-2721 administration and post- or preirradiation Broncho-Vaxom… Expand
1984
1984
In a 6-month placebo-controlled double-blind multicenter study in 230 patients with recurrent respiratory tract infections, the… Expand